ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
64 010,78
0,95%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Hikma Pharmaceuticals Plc (HIK)

  7. Hikma Pharmaceuticals Plc (HIK) Actualités

HIK Hikma Pharmaceuticals Plc

1 913,00
59,00 (3,18%)
26 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Hikma Pharmaceuticals Plc HIK London Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
59,00 3,18% 1 913,00 17:35:11
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1 861,00 1 861,00 1 920,00 1 913,00 1 854,00
plus d'informations sur les cotations »
Secteur Industriel
PHARMACEUTICALS & BIOTECHNOLOGY

Actualités Recentes

Date Heure Source Titre
25/4/202415:28UK RNSHikma Pharmaceuticals Plc Result of AGM
25/4/202411:15ALNCNewsHikma Pharmaceuticals backs outlook after making strong..
25/4/202408:00UK RNSHikma Pharmaceuticals Plc Trading Statement
17/4/202411:42UK RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
15/4/202417:43UK RNSHikma Pharmaceuticals Plc Hikma appoints new President of..
11/4/202411:58UK RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
02/4/202410:50UK RNSHikma Pharmaceuticals Plc Block listing Interim Review
22/3/202410:21UK RNSHikma Pharmaceuticals Plc Annual Financial Report and Notice..
13/3/202410:42UK RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
07/3/202414:52UK RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
01/3/202411:17UK RNSHikma Pharmaceuticals Plc Total Voting Rights
22/2/202410:42ALNCNewsTOP NEWS: Hikma boosts dividend after year of "significant..
22/2/202408:09ALNCNews*Hikma Pharmaceuticals says core operating profit to be in..
22/2/202408:00UK RNSHikma Pharmaceuticals Plc Final Results
21/2/202419:20UKREGHikma hosts White House Drug Policy Director Dr. Rahul Gupta..
20/2/202418:24ALNCNewsEARNINGS PREVIEW: Eyes on Hikma's outlook ahead of full-year..
05/2/202413:00UKREGHikma announces US launch of COMBOGESIC® IV
05/2/202409:46UK RNSHikma Pharmaceuticals Plc Notice of Results
01/2/202421:00ALNCNewsEARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's..
01/2/202419:22UK RNSHikma Pharmaceuticals Plc Agreement in Principle for US..
01/2/202413:08UK RNSHikma Pharmaceuticals Plc Total Voting Rights
08/1/202408:30BWGuardant Health and Hikma Partner to Offer Cancer Screening..
02/1/202416:24UKREGHikma Pharmaceuticals Plc Total Voting Rights
29/12/202308:00UKREGHikma Pharmaceuticals Plc Company Secretary Change
01/12/202308:00UKREGHikma Pharmaceuticals Plc Total Voting Rights
02/11/202309:53ALNCNewsTOP NEWS: Hikma Pharmaceuticals upgrades Generics and..
02/11/202308:00UKREGHikma Pharmaceuticals Plc Trading Statement
03/10/202313:00PRNUSHikma marks two-year anniversary of KLOXXADO® launch by..
02/10/202311:13UKREGHikma Pharmaceuticals Plc Block listing Interim Review
02/10/202311:04UKREGHikma Pharmaceuticals Plc Total Voting Rights
01/9/202308:00UKREGHikma Pharmaceuticals Plc Total Voting Rights
31/8/202320:06UKREGHikma Pharmaceuticals Plc Director/PDMR Shareholding
30/8/202318:55ALNCNewsTOP NEWS: M&S returns to FTSE 100 after four years,..
23/8/202315:07ALNCNewsIN DEPTH: M&S set for blue-chip return as Hikma-Dechra yo-yo..
22/8/202318:26ALNCNewsTOP NEWS: M&S set to be FTSE 100 outfit again but Persimmon..
11/8/202315:00UKREGHikma Pharmaceuticals Plc Director/PDMR Shareholding
10/8/202317:53UKREGHikma Pharmaceuticals Plc Director/PDMR Shareholding
10/8/202314:28PRNUSRakuten Medical and Hikma Sign Exclusive Licensing Agreement..
09/8/202308:00UKREGHikma Pharmaceuticals Plc Hikma appoints new President of..
03/8/202310:28ALNCNewsHikma posts higher interim revenue; ups guidance for..
03/8/202308:00UKREGHikma Pharmaceuticals Plc Half-year Report
26/7/202318:45PRNUSHikma Ventures invests in Octave Bioscience, a precision..
17/7/202310:11UKREGHikma Pharmaceuticals Plc Notice of Results
15/6/202321:00PRNUSHikma exceeds 150 injectable medicines in the US with launch..
14/6/202311:03UKREGHikma Pharmaceuticals Plc Holding(s) in Company
08/6/202311:25UKREGHikma Pharmaceuticals Plc Director/PDMR Shareholding
31/5/202316:20UKREGHikma Pharmaceuticals Plc Director/PDMR Shareholding
23/5/202317:14UKREGHikma Pharmaceuticals Plc Holding(s) in Company
17/5/202310:56UKREGHikma Pharmaceuticals Plc Director/PDMR Shareholding
02/5/202311:53UKREGHikma Pharmaceuticals Plc Total Voting Rights

Dernières Valeurs Consultées

LSE
HIK
Hikma Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés